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Abstract
Biomechanical strain imposed by age-related thickening of the basal lamina and augmented tissue stiffness in
the prostate gland coincides with increased cancer risk. Here we hypothesized that the structural alterations
in the basal lamina associated with age can induce mechanotransduction pathways in prostate epithelial cells
(PECs) to promote invasiveness and cancer progression. To demonstrate this, we developed a 3D model of PEC
acini in which thickening and stiffening of basal lamina matrix was induced by advanced glycation end-product
(AGE)-dependent non-enzymatic crosslinking of its major components, collagen IV and laminin. We used this
model to demonstrate that antibody targeted blockade of CTLD2, the second of eight C-type lectin-like domains
in Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9, uPARAP) that can recognize glycosylated collagens,
reversed actinomyosin-based contractility [myosin-light chain-2 (MLC2) phosphorylation], loss of cell polarity,
loss of cell–cell junctions, luminal infiltration and basal invasion induced by AGE-modified basal lamina matrix
in PEC acini. Our in vitro results were concordant with luminal occlusion of acini in the prostate glands of
adult Endo180𝚫Ex2–6/𝚫Ex2–6 mice, with constitutively exposed CTLD2 and decreased survival of men with early
(non-invasive) prostate cancer with high epithelial Endo180 expression and levels of AGE. These findings indicate
that AGE-dependent modification of the basal lamina induces invasive behaviour in non-transformed PECs via a
molecular mechanism linked to cancer progression. This study provides a rationale for targeting CTLD2 in Endo180
in prostate cancer and other pathologies in which increased basal lamina thickness and tissue stiffness are driving
factors.
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Introduction
Structural changes in the basal lamina during ageing
include altered matrix composition, organization and
progressive thickening [1,2]. The extent of these alter-
ations is organ-specific and exacerbated by metabolic or
endocrine disorders [3–5]. Age-related reorganization
of the basement membrane in prostate gland acini
was reported four decades ago and indicated that its
thickness can increase from 400–700 Å in younger
(4–6 months) mice to 3000 Å in older (29–36 months)
mice [3]. Given that progressive prostate enlargement
and stiffening occurs during the common age-related
and metabolic condition benign prostate hyperplasia
(BPH) [6], we proposed that this highly tensile environ-
ment can alter prostate epithelial cell (PEC) behaviour
and promote tumour progression.
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Endo180 is a multiple C-type lectin-like domain
(CTLD) receptor that binds to extracellular colla-
gens via its fibronectin type II (FNII) domain [7]
and glycosylated forms of collagen via its second
CTLD, CTLD2 [8]. Endo180 is a highly sensitive
and specific serum marker of metastatic disease in
breast cancer [9], and its expression correlates with
Gleason score and overall survival in prostate cancer
[10,11]. Endo180-dependent prostate cancer progres-
sion involves its functional switch from suppressor to
promoter of epithelial–mesenchymal transition (EMT)
upon its disassociation from CD147 (EMMPRIN, Basi-
gin) and relocalization from the plasma membrane to
endosomes in PEC acini [11]. Given that endosomal
Endo180 enhances myosin-light chain-2 (MLC2) phos-
phorylation and cell migration [12], we postulated that
the basal lamina stiffness triggers Endo180-dependent
PEC invasiveness in the ageing prostate gland.
Materials and methods
Reconstituted basement membrane modification
An adapted protocol [13] was used to crosslink Cultrex®
Culture Matrix™ reduced growth factor-reconstituted
basement membrane (rBM) extract (3445-005-01,
Trevigen®). Eight-well chamber slides were coated
with 30 μl 100% v/v Cultrex® rBM extract and incu-
bated at 37∘C for 30 min. The resultant rBM gels were
incubated at 37∘C for 6 or 14 h with phosphate-buffered
saline (PBS) alone or PBS containing 50 mM glyco-
laldehyde (G6805, Sigma-Aldrich) in 0.2 M phosphate
buffer, pH 7.8, followed by quenching with 1 M glycine
ethyl ester hydrochloride (50060, Sigma-Aldrich); 50
mM sodium cyanoborohydride (71435, Sigma-Aldrich)
and 250 mM aminoguanidine hydrochloride (396494,
Sigma-Aldrich) were respectively used to reduce Schiff
bases and quench reactive aldehydes, preventing AGE
formation. rBM gels were washed with PBS (5 min,
five times), incubated in PBS at 37∘C (16 h) and washed
with PBS (5 min, three times). For analysis, rBM gels
were centrifuged at high speed (5 min), resuspended in
500 ml 70% v/v formic acid and 20 mg/ml cyanogen
bromide (C91492, Sigma-Aldrich) in 2 g/ml acetonitrile
(271004, Sigma-Aldrich), incubated at room temper-
ature (16 h) and dialysed against water. Fluorophore
production associated with AGE generation was deter-
mined (excitation wavelength= 370 nm; absorbance
wavelength= 440 nm; PHERAstar Plus spectropho-
tometer, BMG Labtech). Corresponding rBM gel
samples were resolved on 12% v/v SDS–PAGE gels
(reducing conditions) and visualized (PageSilverTM,
Fermentas). For microscopic analysis of collagen IV
and laminin fibres, eight-well chamber slides con-
taining rBM gels were washed with PBS, fixed [4%
w/v paraformaldehyde (PFA) diluted in PBS, 30 min],
quenched (100 mM glycine in PBS; 10 min, three times)
and incubated at room temperature (1 h) in 1% w/v
bovine serum albumin (BSA) and 2% v/v fetal calf
serum (FCS) diluted in PBS, before immunostaining
with rabbit anti-human collagen IV polyclonal antibody
(pAb; R1041, Acris Antibodies) and rabbit anti-human
laminin pAb (sc-5583, Santa Cruz). Samples were
fixed and quenched (see above), washed with PBS (5
min, twice), mounted in Vectashield® and analysed by
confocal microscopy (Zeiss Confocal Axiovert 200M
operated by LSM510 META software). For rheometry,
8 mm diameter× 1 mm thick rBM gels were analysed
at 21∘C with an ARG2-controlled strain rotational
rheometer (TA Instruments), using 8 mm parallel plate
serrated geometry, 1–3% strain and fixed frequency
oscillation of 1 Hz. Gels displayed minimal frequency
dependence and a linear viscoelastic response at these
settings. The elastic modulus (E) was determined from
the shear storage modulus (G′), using the equation
E = 2×G′ × (1+ v), where v=Poisson’s ratio (0.5).
Acinar morphogenesis and analysis
RWPE-1 cells were obtained from the American
Type Culture Collection, where they were verified
by short tandem repeat profiling and phenotypic
analysis. Cells were tested for mycoplasma every 3
months (VenorTMGeM) and used up to 10 passages for
experiments. RWPE-1 cells were grown in complete
keratinocyte serum-free medium (17005-075, Invitro-
gen). A modified method [14] was used to generate PEC
acini. RWPE-1 cells were seeded (0.5× 104 cells/cm2)
on PBS-treated (native) or glycolaldehyde-treated
(stiff) rBM gels, overlaid with complete keratinocyte
serum-free medium containing 2% v/v rBM, and cul-
tured in a 5% v/v CO2 incubator at 37
∘C (6 days)
and mouse anti-human Endo180 mAb clone A5/158
[15] or non-specific isotype control IgG antibody
(ab37355-1, Abcam), both at 10 μg/ml, included where
indicated and replaced every 24 h. Three blinded scor-
ers calculated the shape distribution of the acini prior
to fixation, using an arbitrary system to score acini
as round (smooth basal interface), semi-polygonal
(irregular basal interface) or polygonal (protrusive
basal interface). Relative acinar size and luminal area
were calculated from confocal microscopy images of
acini immunostained with phalloidin AlexaFluor® 488
(A12379, Invitrogen) and TO-PRO®-3-iodide nuclear
counterstain (T3605, Sigma-Aldrich), using ImageJ
v 1.44p algorithms. Acinar and luminal areas were
calculated in pixels and values normalized against
corresponding untreated samples (set at 100%). The
percentage of acini with >1 basal protrusions was
quantified from epifluorescent images of acini stained
with 4′,6-diamidino-2-phenylindole (DAPI; D3571,
Sigma-Aldrich). The percentages (mean±SD) were
quantified (50 acini/treatment) for three independent
experimental repeats.
Immunofluorescent staining
RWPE-1 acini grown in eight-well chamber slides were
washed in PBS+ (0.1 mM CaCl2 and 0.5 mM MgCl2;
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5 min each, twice), fixed in 4% w/v PFA in PBS+ (30
min) and quenched with 75 mM NH4Cl +0.5 mM MgCl2
(5 min, five times). The acini were permeabilized in
0.5% v/v Triton-X100 in PBS (30 min) and incubated in
immunofluorescence buffer (IFB; 130 mM NaCl, 7 mM
Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1% w/v
BSA, 0.5% v/v Triton X-100 and 0.05% v/v Tween-20),
complemented with 20% v/v non-immune goat serum
(ab7481, Abcam) on a shaking platform (2 h). The cul-
tures were incubated at 4∘C (16 h) with primary antibod-
ies diluted in IFB at the following dilutions: 1/500 mouse
anti-pentosidine, clone PEN-12 mAb (KH012, Trans-
Genic Inc.), 1/250 rabbit anti-human collagen IV poly-
clonal antibody (pAb; R1041, Acris Antibodies), 1/250
rabbit anti-human laminin pAb (sc-5583, Santa Cruz),
1/250 rabbit anti-human E-cadherin pAb (3195, Invit-
rogen), 1/250 mouse anti-GM130 mAb clone EP892Y
(ab52649; Abcam), 1/100 mouse anti-EEA1 mAb clone
14/EEA1 (610457, BD Transduction Laboratories) and
Endo180 mAb (clones A5/158 and 39.10) [12,15,16]
and washed in IFB at room temperature (10 min, three
times). AlexaFluor goat anti-rabbit or anti-mouse IgG
(H+L) secondary antibody conjugates were diluted
1/500 in IFB, added to cultures and incubated at room
temperature (2 h). Following washing in IFB and PBS+
(10 min each, three times), the acini were fixed and
quenched as described above. Cell nuclei were stained
with TO-PRO®-3-iodide (T3605, Sigma-Aldrich) (5
min), washed with PBS+ (5 min, twice) and mounted
in Vectashield® (H1000, Vector Laboratories), and epi-
fluorescent and confocal images were acquired using
a Zeiss Axiovert S100 microscope operated by Meta-
Morph software, and a Zeiss Confocal Axiovert 200M
operated by LSM510 META software, respectively.
Western blot analysis
Immunoblotting was carried out as previously described
[16], using the following primary antibody dilutions:
1/1000 anti-Endo180 clone CAT2 pAb [17], 1/1000
mouse anti-human β1-integrin mAb clone 12G10
(MCA2028, AbD Serotec), 1/1000 anti-E-cadherin
pAb, 1/10000 anti-GAPDH (ab9485, Abcam), 1/500
rabbit anti-phospho-MLC2 (Thr18/Ser19) pAb (3674S,
New England Biolabs), 1/1000 mouse anti-myosin
light chain (4401, New England Biolabs); followed by
1/5000 HRP-conjugated goat anti-rabbit IgG (sc-2004,
Santa Cruz) or 1/500 HRP-conjugated AffiniPure
goat anti-mouse IgG (H+L; 115-035-174, Jackson
Immunoresearch Laboratories). Relative signal intensi-
ties were quantified from immunoblots by densitometric
analysis (Image J v 1.42q) and normalized against
mouse IgG-treated controls and native rBM control gels
(reference for native rBM gels and mouse IgG= 1 U)
and adjusted for loading against GAPDH levels.
Analysis of mouse tissue
Wild-type and Endo180ΔEx2 –6/ΔEx2 –6 mice were geno-
typed for the Endo180 allele by Southern blot analysis
[17,18]. Prostate glands were excised and fixed in 4%
w/v paraformaldehyde prior to processing. Sections
were deparaffinized in 100% v/v xylene (30 min, twice)
and hydrated in graded ethanol solutions (100%, 95%,
70% v/v) and then double-distilled water. Antigen
retrieval was performed using 20 μg/ml Proteinase K
diluted in TE buffer at 37∘C (30 min), boiling in 1 mM
EDTA, pH 8 (10 min), washing in PBS (10 min, three
times) and inactivation of endogenous peroxidase in
3% v/v hydrogen peroxidase (10 min). After washing in
PBS (5 min, three times), the samples were incubated (1
h) in blocking solution (PBS +20% w/v FBS). Sections
were incubated with anti-collagen IV (R1041, Acris
Antibodies) or anti-laminin (sc-5583, Santa Cruz, 1/50
in blocking solution) at 4∘C (16 h), washed in PBS (5
min, three times), incubated with AlexaFluor-488 goat
anti-rabbit IgG (H+L) diluted in blocking solution
(1 h), washed in PBS (5 min, three times), counter-
stained with DAPI, washed with PBS (5 min, twice) and
mounted in Vectashield®. Images were acquired using
a Zeiss S100 Axiovert epifluorescent/brightfield micro-
scope. Densitometric analysis was performed using
ImageJ algorithms to calculate the ratio of immunos-
tained area (pixels) divided by the average intensity
of background (pixels). To analyse luminal obstruc-
tion, the following assumption was made: one luminal
epithelial cell layer= hollow; two luminal epithelial cell
layers= partial obstruction; and more than two luminal
epithelial cell layers= complete obstruction. Collagen
IV and laminin intensities and luminal obstruction
were calculated from sections of anterior and ven-
tral prostates obtained from five wild-type and six
Endo180ΔEx2–6/ΔEx2–6 adult (age >18 months) mice.
Analysis of human tissue
Tissue biopsies on the NCLPC1 and NCLPC4 prostate
cancer TMAs used in this study were obtained with con-
sent and approved by the Research Ethics Committee of
Newcastle University Medical School. IHC was carried
out using a Bond III fully automated staining system
and Bond Polymer Refine Detection (Leica Microsys-
tems). Antigen retrieval was carried out using Epitope
retrieval, pH 6 (100∘C, 30 min). 1/2500 rabbit anti-AGE
pAb (ab23722, Abcam; performed at Imperial College
London) or 1/50 anti-Endo180 (39.10; performed at
Newcastle University) were applied to tissue sections
(30 min) and 1× diaminobenzidine was used as a chro-
mogen. The sections were counterstained with Mayer’s
haematoxylin (MHS1, Sigma-Aldrich) and mounted in
Faramount aqueous medium (S3025, Dako). Immunos-
taining was quantified as percentage positive epithelial
cells (0–100)× staining intensity (0–3), giving possible
scores of 0–300. Two cores were evaluated from each
tumour and the mean calculated. If one core was unavail-
able, the value for the remaining core was used. A cut-off
score of 30 defined positive versus negative tumours was
used. This immunohistochemical scoring system is in
routine use in the Departments of Medicine and Surgery
and Cancer at Imperial College London [19].
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Statistics
Statistical significance was evaluated using two-tailed
Student’s t-test (α= 0.05). Kaplan–Meier analysis, log
rank, Breslow and Tarone-Ware tests were conducted,
using SPSS v 19.0 statistical software (SPSS Inc.).
Assumption of proportional hazard was tested for all




non-enzymatic crosslinking of the basal lamina as a
model for its structural alteration during ageing
To simulate increased thickness and stiffness of the
basal lamina associated with ageing, glycolaldehyde
was used to non-enzymatically crosslink rBM matrix
by promoting Schiff base adduct formation, Amadori
rearrangement and subsequent advanced glycation
end product (AGE) generation. AGE generation was
determined by the measurement of fluorophores in
glycolaldehyde-treated rBM [13]. Fluorophore produc-
tion associated with AGE generation was effectively
blocked by the Schiff base reducing agent, sodium
cyanoborohydride, and the reactive aldehyde quencher,
aminoguanidine (see supplementary material, Figure
S1A). The formation of high molecular weight rBM
protein fragments that were not able to penetrate
SDS–PAGE gel (see supplementary material, Figure
S1B) and structural rearrangement of the rBM major
matrix components, collagen IV and laminin, into dense
bundles (see supplementary material, Figure S1C, D),
confirmed that glycolaldehyde treatment induced the
formation of crosslinks. Rheometric analysis confirmed
that there was a significant increase in the elastic moduli
of rBM following its treatment with glycolaldehyde for
6 h (175± 90 Pa) or 14 h (322± 160 Pa), compared to its
treatment with PBS (120± 55 Pa) (see supplementary
material, Figure S1E). Herein, the following nomen-
clature describes the different biomechanical properties
of rBM after these three pretreatments: ’native’ (14
h PBS); ’semi-stiff’ (6 h glycolaldehyde); and ’stiff’
(14 h glycolaldehyde). Importantly, the 3.2± 2.0-fold
increase in elastic modulus after 14 h pretreatment with
glycolaldehyde was concordant with the 2.5- to 3.4-fold
increase in stiffness observed in malignant versus nor-
mal prostate tissue (see supplementary material, Figure
S1E, Table S1) [20–25].
AGE-modified basal lamina induces PEC
invasiveness
To ascertain whether basal lamina stiffness can pro-
mote tumourigenic behaviour in normal prostate epithe-
lia, we compared three-dimensional (3D) acinar struc-
tures generated by non-transformed PECs (RWPE1
cells) in native, semi-stiff and stiff rBM. AGE gen-
eration in stiff rBM was detected by immunostaining
of pentosidine, an indicator of collagen IV crosslink-
ing [26] and a biomarker for tissue stiffness [27], and
was associated with increased thickness of the colla-
gen IV and laminin layer that assembled around PEC
acini (Figure 1A). The marked depletion of collagen
IV and laminin at points of PEC protrusion from the
basal surface of the acini, together with mislocalization
of markers of cell–cell adhesion (E-cadherin) and api-
cal polarity (GM130; early endosomal antigen-1, EEA1)
induced by glycated and crosslinked rBM (Figure 1A),
suggests that a stiff microenvironment contributes to the
induction of their invasive behaviour. The fact that stiff-
ened rBM did not promote polyADP ribose polymerase
(PARP) cleavage (see supplementary material, Figure
S2) confirmed that the levels of AGE generation and
stiffness used in our model had no effect on cell viabil-
ity. In keeping with these findings, acinar morphogen-
esis proceeded at similar rates on native and stiff rBM
(see supplementary material, Figure S3). Comparison of
PEC acini in native and stiff rBM (Figure 2A) revealed
a significant transition towards an irregular (polygonal)
shape (Figure 2B), accompanied by a 0.8-fold reduc-
tion in size (Figure 2C) and a 0.4-fold decrease in
luminal:total area ratio (Figure 2D) on the latter. The
respective 1.8-fold and 2.8-fold increases in the num-
ber of acini with PECs visibly protruding from their
basal surface into semi-stiff and stiff rBM (Figure 2E)
confirmed that high AGE content and stiffened basal
lamina induces invasive behaviour in non-transformed
PECs. These findings were validated in an alterna-
tive experimental system, in which ribose was used to
non-enzymatically crosslink rBM and shown to induce
similar changes in PEC acinar morphology (see supple-
mentary material, Figure S4A–D). The promotion of
PEC invasion from the basal surface of acini, breakage
of the basal lamina at points of PEC protrusion, reduc-
tion in luminal area and loss of epithelial cell polarity
facilitated by AGE-induced stiffness of the basal lamina
suggests that this biophysical change can trigger inva-
sive behaviour in the prostate gland.
AGE-modified basal lamina induces
Endo180-dependent contractile signalling and PEC
invasiveness
In relation to the induction of PEC invasiveness by
AGE-dependent basal lamina stiffness, we tested the
hypothesis that CTLD2, which directly binds to gly-
cosylated collagens, including basement membrane
collagen IV [8], is a mechanotransducer that directs
the response of PECs to this environmental change
(Figure 1B). In support of this theory, immunostain-
ing with a mouse anti-human Endo180 monoclonal
antibody (mAb), A5/158, that recognizes CTLD2
(Figure 1B) [15], revealed that endogenously expressed
Endo180 is strongly localized at the basal surface of
PEC acini in native rBM (Figure 1C), where it is able to
bind to extracellular glycated collagens. Immunostain-
ing with a second mouse anti-human Endo180 mAb,
39.10, detected Endo180 exclusively in endosomes
Copyright © 2014 Pathological Society of Great Britain and Ireland. J Pathol 2015; 235: 581–592
Published by John Wiley & Sons, Ltd. www.pathsoc.org.uk www.thejournalofpathology.com
How a stiff microenvironment promotes prostate cancer progression 585
Figure 1. AGE-modified rBM affects apical–basal polarity and Endo180 subcellular localization in PEC acini. (A) Confocal microscopy images
of acini grown in native or stiff rBM: TOPRO-3 nuclear stain (blue) and AGE (pentosidine), rBM matrix (collagen IV and laminin), lateral
cell–cell junctions (E-cadherin) and apical polarity (GM130 and EEA1; green). (B) Glycosylated collagen IV binds to CTLD2 in Endo180 and
is proposed to induce PEC invasiveness: putative ‘closed’ and ‘open’ conformations of Endo180 exist in native and stiff rBM, respectively;
the ligand-binding domains in Endo180 recognized by A5/158 mAb (CTLD2) and 39.10 mAb (CTLD4) are indicated; interaction of Endo180
with highly glycosylated CD147 at the basal plasma membrane is predicted to mask the epitope for 39.10 mAb. (C) Confocal images of the
distinct subcellular localizations of Endo180, visualized using A5/158 mAb (basal) and 39.10 mAb (endosomal); arrow, invasive PEC with
strong intracellular localization of Endo180; scale bars= 10 μm; data are representative of three independent experimental repeats.
(Figure 1C), due to its epitope CTLD4 (Figure 1B)
being masked by its interaction with CD147 at the
basal surface of PEC acini [11]. Interestingly, levels of
endosomal Endo180 were visibly increased in PECs
protruding from the basal surface of acini into stiff
rBM (Figure 1C, arrow). Moreover, targeted blockade
of CTLD2 by A5/158 mAb decreased the transition
of PEC acini towards a polygonal shape (0.6-fold),
decreased the basal protrusion of PECs (0.7-fold) and
increased acinar size (2.2-fold) in comparison to IgG
control treatment (Figure 3A–D). The anti-invasive
effects of A5/158 mAb treatment were recapitulated in
our alternative ribose-based model (see supplementary
material, Figure S4E).
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Figure 2. AGE-modified rBM induces apical and basal acinar PEC invasiveness. (A) (top) confocal microscopy images of PEC acini cultured
on native, semi-stiff or stiff rBM with TOPRO-3 nuclear stain (blue) and phalloidin F-actin stain (green); scale bar= 20 μm; (middle)
epifluorescent microscopy images of acini with DAPI nuclear stain; scale bar= 60 μm; (bottom) detail of one acinus from each condition;
arrow, cell protruding from basal surface; scale bar= 10 μm. (B) Shape distribution of acini in native, semi-stiff and stiff rBM for 6 days (%,
mean± SD); graphs show (C) relative acinar size (native rBM= 100%); (D) luminal:total area ratio of acini; (E) acini with cells protruding
at basal surface: all graphs show values (%, mean± SD for 50 acini) for native (black bars), semi-stiff (dark grey bars) and stiff (light grey
bars) rBM and are representative of three independent experimental repeats.
We next considered whether the pro-invasive signals
activated by stiff rBM in our 3D PEC acinar model
involved the pro-migratory, actinomyosin-based, cell
contractility signals generated by Endo180-containing
endosomes in two dimensional (2D) culture mod-
els [12]. To explore this, pMLC2, total MLC2 and
Endo180 levels were measured using immunoblot
analysis of lysates generated from PEC acini cultured
in native and stiff rBM in the presence or absence of
control IgG or A5/158 mAb (Figure 4A). Stiff rBM
induced a 1.3-fold increase in the pMLC2:MLC2
ratio, which was reduced to 0.3-fold by A5/158 mAb
treatment (a decrease of ∼77%) without changing
Endo180 expression (Figure 4B). The A5/158-sensitive
(CTLD2-dependent) phosphorylation of MLC2 asso-
ciated with increased rBM stiffness directly correlated
with a decrease in E-cadherin and an increase in
β1-integrin (Figure 4B). The stiffness-induced changes
in E-cadherin and β1-integrin levels were restored
in PEC acini by A5/158 mAb treatment (E-cadherin
from 0.6-fold to 1.0-fold; β1-integrin from 1.6-fold
to 0.8-fold) (Figure 4B). These findings suggest that
CTLD2-dependent actinomyosin-based contractil-
ity signals generated in PECs, at stiff basal lamina
interfaces, drive their increased invasion.
Endo180 modulates its extracellular matrix
remodelling partners in AGE-modified basal lamina
Given its role in collagen remodelling, we considered
whether cooperative protease partners of Endo180,
co-expressed on invasive PECs in human prostate
tumours [10], were under the regulatory control
of Endo180 under stiff conditions. Accordingly,
A5/158 mAb treatment reversed the up-regulation
of membrane-type 1 matrix metalloproteinase
(MT1-MMP; from 1.3-fold to 0.8-fold) and urokinase
plasminogen activator (uPA; from 1.2-fold to 0.5-fold)
in stiff rBM (see supplementary material, Figure S5A).
These findings point towards a modulatory role for
Endo180 in directing pericellular proteolysis during
PEC invasion through a stiffened basal lamina. However,
A5/158 mAb did not inhibit collagen uptake by PECs
(see supplementary material, Figure S5B), indicating
that Endo180-dependent clearance of collagen degrada-
tion products is not necessary for PEC invasiveness.
Prostate acini in Endo180 mutant mice have
luminal obstruction and reduced BM matrix
Our in vitro findings support the hypothesis that CTLD2
binding to modified collagen IV [8] in a stiffened basal
lamina can promote PEC invasiveness (Figure 2A). To
establish whether CTLD2 in Endo180 contributes to
remodelling of prostate epithelia in vivo, we investigated
the consequence of a targeted genetic modification in the
MRC2 gene that results in CTLD2 being constitutively
exposed in a truncated form of the transcribed receptor
(Figure 5A) [17,18]. This truncation in Endo180 simu-
lates the ‘open’ conformation of the receptor that is pre-
dicted to exist in the acidic environment of endosomes
(Figure 5A) [28–30].
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Figure 3. Endo180-dependent PEC invasion in AGE-modified rBM. (A) (top) Confocal images of acini treated with IgG or A5/158 mAb (10
μg/ml) in stiff rBM; TOPRO-3 nuclear stain (blue); phalloidin F-actin stain (green); scale bar= 20 μm; (middle) epifluorescent images of
acini with DAPI nuclear stain; scale bar= 60 μm; (bottom) detail of a single acinus under each condition; arrow, cell protruding from basal
surface; scale bar= 10 μm. Graphs show: (B) acinar shape distribution; (C) cell protrusion at the basal surface; and (D) relative acinar size
(native rBM= 100%), in the presence of IgG or A5/158 in native (black bars) or stiff (light grey bars) rBM. All graphs show values (%,
mean± SD for 50 acini) quantified per condition and are representative of three independent experimental repeats.
Interestingly, respective reductions were observed
in levels of the core basal lamina matrix components,
collagen IV and laminin, in the ventral (0.7-fold and
0.6-fold) and anterior (0.8-fold and 0.7-fold) regions of
the prostate glands of Endo180ΔEx2–6/ΔEx2–6 mice com-
pared to their wild-type counterparts (Figure 5B–D).
Moreover, the modified basal lamina in mutant
mice, with exposed CTLD2, was accompanied by
an increase in complete cellular obstruction of aci-
nar lumen in the ventral (1.7-fold) and anterior
(1.9-fold) prostate, when compared to wild-type ani-
mals (Figure 5E–G), which is indicative of lesion
development.
Endo180 combined with AGE decreases prostate
cancer survival
AGE accumulation in human tissue is a hallmark of
several age-related diseases, including multiple cancer
types (reviewed in [31]). The interaction of AGE with its
receptor, RAGE, is linked to the promotion of prostate
cancer cell growth and invasion [32,33]; and the expres-
sion of RAGE and its ligand high-mobility group box 1
(HMBG1) has been associated with poor overall survival
in a cohort of 58 patients with clinical stage III and IV
prostate cancer [34]. Our in vitro findings suggest that
prostate cancer has the potential to progress when the
basal lamina becomes stiffened by AGE exposure and
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Figure 4. Endo180-dependent actinomyosin-based signal transduction in AGE-modified rBM. (A) Immunoblots show pMLC2, total MLC2,
Endo180, E-cadherin, β1-integrin and GAPDH levels in PEC acini cultured in native or stiff rBM in the presence of IgG or A5/158; MW markers
(kDa). (B) Graph shows relative levels of pMLC2, MLC2, pMLC2:MLC2 ratio (grey shading), Endo180, E-cadherin and β1-integrin calculated
from densitometric analysis of immunoblots adjusted against GAPDH loading control (native rBM+ IgG= 1). All data are representative of
three independent experimental repeats.
triggers Endo180-dependent mechanotransduction and
invasion of PECs.
Immunostaining of two University of Newcastle
tissue microarrays (NCLPC1 and NCLPC-4; see sup-
plementary material, Table S2) revealed high levels of
epithelial AGE in 55% (68/123) of prostate tumours
(Figure 6A). Kaplan–Meier analysis revealed that
high epithelial AGE content per se was not prognostic
(Figure 6B), whereas high epithelial AGE accumula-
tion combined with an Endo180-positive, but not an
Endo180-negative, status (Figure 6A) was predictive
of a decrease in overall survival (Figure 6C). In the
subset of men with prostate tumours with high epithe-
lial AGE content, 62% (31/50) deaths were recorded
after 5 years in the Endo180-positive group, which
was significantly higher (p <0.016) than the 28%
(5/18) deaths recorded in the Endo180-negative subset
(Figure 6C; see also supplementary material, Table S3).
Endo180 had less impact on the 5-year survival rate of
men with AGE-negative prostate tumours, with 69%
(29/42) deaths in the Endo180-positive subset and 54%
(7/13) deaths in the Endo180-negative subset (p= 0.4)
(Figure 6D; see also supplementary material, Table
S3). This compelling evidence links the expression of
Endo180 in epithelial cells, in an environment associated
with increased non-enzymatic crosslinking and stiffen-
ing of the basal lamina, to the switch from indolent to
aggressive prostate cancer and reduced survival.
Discussion
Here we show that the progressive thickening and stiff-
ening of the basal lamina associated with normal ageing
and metabolic disease [1–6] can induce normal PEC
invasiveness. The study introduces a novel 3D model of
PEC acini grown in rBM matrix that has been subject
to non-enzymatic crosslinking by AGE, recapitulating
basal lamina thickening in the ageing mouse prostate,
and the increased levels of tissue stiffness observed
in prostate cancer (see supplementary material, Figure
S1E, Table S1) [20–25]. The findings are supported by
in vivo and clinical evidence that link Endo180 dysfunc-
tion to basal lamina degradation, accompanied by lumi-
nal obstruction of prostate acini and the cooperation of
Endo180 with AGE in the promotion of prostate cancer
progression.
In line with our previous studies, where Endo180 has
been shown to play a role in EMT and prostate can-
cer progression [10,11], and the spatiotemporal activa-
tion of actinomyosin-based contractile signals and cell
migration [12], we propose a model in which two func-
tional CTLDs in Endo180, CTLD2 and CTLD4, are
responsible for directly modulating PEC invasiveness
(see supplementary material, Figure S6). We believe that
the molecular basis of this regulation involves a switch
between the closed and open conformation of Endo180’s
ectodomain [28–30]. We speculate that, under normal
tissue conditions, Endo180 adopts a closed conforma-
tion and maintains acinar homeostasis via the interaction
of its CTLD4 with CD147 at the plasma membrane and
its FNII domain with collagen IV at the basal lamina
interface; whereas in stiff microenvironments it is pro-
posed that Endo180 adopts an open conformation that
allows it to sense crosslinked collagen fibres, promot-
ing actinomyosin-based contractility and driving PEC
invasion through the basal lamina. Given that antibody
blockade of CTLD2 in Endo180 can partially block the
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Figure 5. Acinar luminal obstruction is induced in the prostates of Endo180ΔEx2–6/ΔEx2–6 mice. (A) Truncated Endo180 receptor in
Endo180ΔEx2–6/ΔEx2–6 mice and proposed conformational change in Endo180 under stiff conditions. (B) Epifluorescent images of ventral
prostate sections from wild-type mice and Endo180ΔEx2–6/ΔEx2–6 mice; TOPRO-3 nuclear stain (blue), collagen IV (green) and laminin (red);
scale bar= 50 μm. (C) Ratio of relative staining:background intensity (mean± SD) for collagen IV (black bars) or laminin (grey bars) in
ventral prostates of wild-type and Endo180ΔEx2–6/ΔEx2–6 mice. (D). Analysis in (C) conducted on anterior prostates. (E) Epifluorescent images
of ventral prostate sections from wild-type and Endo180ΔEx2–6/ΔEx2–6 mice; TOPRO-3 nuclear stain (blue), collagen IV (green); extent of
luminal obstruction (hollow, partial and complete luminal obstruction); scale bar= 50 μm. Graphs show extent of luminal obstruction (%,
mean± SD for 50 acini) in ventral (F) and anterior (G) prostate glands of five wild-type mice (black bars) and six Endo180ΔEx2–6/ΔEx2–6 mice
(grey bars).
invasive phenotype induced by the stiff basal lamina, it is
plausible that this approach could be of therapeutic ben-
efit in prostatic and other disease pathologies in which
basal lamina thickness and stiffness is identified as a
driving factor (see supplementary material, Figure S7).
Loss of collagen IV and laminin in the prostate gland
of mutant Endo180ΔEx2–6/ΔEx2–6 mice indicates that
the homeostasis of basal lamina turnover is defective
in these animals. The mechanisms underpinning this
phenomenon could involve activation of proteases that
degrade the basal lamina or defective production and
organization of its matrix components. The first mecha-
nism is supported by the finding that Endo180 forms an
EMT-suppressor complex with the extracellular matrix
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Figure 6. High epithelial AGE and Endo180 predict poor prognosis in men with prostate cancer. Immunohistochemistry of NCLPC1 and
NCLPC4 tissue microarrays (n= 157) stained with rabbit anti-AGE pAb (0.4 μg/ml; brown) and Mayer’s haematoxylin nuclear counterstain
(blue). (A) Examples of tumour tissue cores with positive or negative epithelial AGE and Endo180 immunostaining; scale bar= 100
μm. Kaplan–Meier 5 year survival analysis of pooled data (NCLPC1+NCLPC4) for: (B) epithelial AGE-negative (score≤ 30, black line)
versus epithelial AGE-positive (score ≥30, grey line) tumours; and epithelial Endo180-negative (score≤ 30, black lines) versus epithelial
Endo180-positive (score ≥30, grey lines) tumours in (C) epithelial AGE-positive and (D) AGE-negative patients; p ≤ 0.05, significant for
log-rank, Breslow and Tarone–Ware tests. Table S3 (see supplementary material) shows patient deaths (censored) after 3, 5, 7 and 10 years.
metalloproteinase inducer CD147 [11], and its targeted
blockade results in down-regulation of MT1-MMP
and uPA (see supplementary material, Figure S5),
which both drive basal lamina matrix degradation
[35–38]. The latter mechanism is supported from the
finding in a different cellular context, whereby Endo180
orchestrates collagen deposition by primary human
osteoblasts [16].
The in vitro systems used to model early tumouri-
genesis or tumour progression in response to tissue
stiffness used constitutively active Ras transformation
in a single Madine Derby canine kidney epithelial
cell, or ErbB2 activation in a single MCF10A mam-
mary gland epithelial cell, localized in corresponding
non-transformed epithelial layers [39–41]. Although
conceptually intriguing, these models do not explain
how epithelial cancers arise when aberrant Ras or
ErbB2 signalling are absent, as in the prostate gland,
where mutations in either oncogene are rare [42,43].
The intriguing paradigm presented here suggests that
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biomechanical modification of the basal lamina is an
independent trigger for PEC invasiveness.
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